In this perspective, we propose that T2D and CVD should not merely be considered co-occurring conditions, but rather co-evolving manifestations of a shared pathophysiological trajectory, driven by systemic inflammation, insulin resistance, adipose tissue dysfunction, and maladaptive neurohormonal responses. This evidence concerns the gene INS and type 2 diabetes mellitus.